← Open Payments lookup

RICHARD MULLIN: Open Payments

NPI 1851598668 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$172 in 9 payments from 8 companies in 2025. Trend: 2023 $463 · 2024 $314 · 2025 $172

Food & beverage: $172
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.2$29
Alkermes, Inc.1$27
Vanda Pharmaceuticals Inc.1$24
Otsuka America Pharmaceutical, Inc.1$21
Eisai Inc.1$20
Neurocrine BioSciences, Inc.1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$16
ABBVIE INC.1$16

Products named: TRINTELLIX, VIVITROL, FANAPT, ABILIFY ASIMTUFII, Leqembi, INGREZZA, CAPLYTA, VRAYLAR.

Industry payments across NY — which companies pay providers there.